BioSpace News Archive

Dry mouth, or xerostomia, occurs due to the absence of the generation of saliva.

DNA synthesizers are systems used to build DNA molecules containing a particular sequence of nucleotides. Synthesizers can create specific DNA molecules for use in the treatment of various diseases by replacing a faulty or damaged section of DNA with a repaired section.

Aridis Pharmaceuticals, Inc. announced the Company will present at the ROTH Capital Partners 2020 MedTech Innovation Forum on Wednesday, October 28, 2020.

Extended range of services supports accelerated drug discovery and development using predictive 3D Liver-on-Chip technology

Trimedic Therapeutics has submitted to Health Canada an application for the importation and sale of its COVID-19 rapid antigen test under the Interim Order pathway.

Centene Corporation announced its financial results for the third quarter ended September 30, 2020, reporting diluted earnings per share of $0.97 and Adjusted diluted EPS of $1.26, including the risk corridor, charitable contribution commitment to the Company’s foundation and tax benefit highlighted below.

Abeona Therapeutics Inc., a fully-integrated leader in gene and cell therapy, announced that Michael Amoroso, Senior Vice President and Chief Commercial Officer at Abeona, has been promoted to Chief Operating Officer and will serve as the Company’s principal executive and operating officer, effective November 1, 2020.

Synlogic, Inc., a clinical stage company bringing the transformative potential of synthetic biology to medicine, announced the Company will release its third quarter 2020 financial results before the market opens on Thursday, November 5, 2020.

Waters Corporation announced third quarter 2020 sales of $594 million, a 3% increase as reported, compared to sales of $577 million for the third quarter of 2019.

Filings based on robust abrocitinib clinical trial data demonstrating significant symptom improvement versus placebo as well as a consistent safety profile